Pharmaceutical Technology

SEPTEMBER 22, 2022

Avrobio has received rare pediatric disease designation from the US Food and Drug Administration (FDA) for its investigational gene therapy, AVR-RD-04, designed to treat cystinosis. AVR-RD-04 works by genetically modify a patient's hematopoietic stem cells (HSCs) to express the gene that encodes the cystinosin protein.

59

59

The Thyroid Pharmacist

JULY 7, 2023

After the nine-month trial, there was a significant decrease in serum TSH and TPO antibodies (a 54 percent reduction!), 32] During the trial, serum thyroid stimulating hormone (TSH) levels reduced from an average of 6.42 A dosage of 200 mcg per day has been found to reduce thyroid antibodies in clinical trials. [41]

Immunity 104

Immunity Immunization Diabetes Dosage 104

The Thyroid Pharmacist

AUGUST 26, 2022

In clinical studies, many patients with ASD have increased levels of propionic acid in the stool, as well as a history of previous infections; many also have carnitine deficiency. Clinical trials have shown that some carnitine forms, such as ALCAR, reduce pain and vascular-related symptoms in diabetic patients as well. (5).

Diabetes 86

Diabetes Immunity Immunization Chemotherapy 86